Global Central Laboratory Facilities & Services

Wholly-owned global laboratory facilities located in the US, Belgium, China, and Singapore

Medpace provides customized, high-quality central laboratory services to pharmaceutical and biotech clinical development industries. Our four wholly-owned laboratories offer full-service support to six continents for phase I-IV studies. We have extensive experience from small and simple clinical trials to those that are large, global, and complex.

Our wholly-owned global laboratory facilities, standardized testing platforms, comprehensive test menu, and stellar project management teams allow Medpace to set up fully customized projects for our clients. Combined with Medpace Clinical Research Organization expertise, we provide a fully integrated solution for your clinical development needs.

Central Laboratories Highlights

Medpace provides laboratory services across 75+ countries delivering best in class science and service supporting today’s complex clinical trials.

Serving some of the world’s largest, most complex clinical trials
Extensive capacity and global scalability in state-of-the-art facilities
Fully-harmonized, high throughput instrumentation delivering high quality data
On-time data transfers with multiple vendor source flexibility to meet client needs
Biomarker development, validation and PD analysis
Industry-leading quick validation timelines
Web-based data portal – ClinTrak Lab – provides seamless data management delivered in a single integrated global database

Client Feedback Tells the Story

Your project’s success rests on the quality we deliver. To ensure we are meeting our client’s high quality expectations, Medpace Central Laboratories compiles site satisfaction surveys on a regular basis. This site survey consists of 15 attributes relating to Medpace project performance. The results include feedback from over 2,000+ sites. Medpace Central Laboratories earns an average of 99% positive responses (satisfactory or excellent ratings) across all attributes rated.